Cellink Ab Stock Performance
| CLLKF Stock | USD 3.01 0.31 9.34% |
The firm shows a Beta (market volatility) of 0.85, which signifies possible diversification benefits within a given portfolio. Cellink AB returns are very sensitive to returns on the market. As the market goes up or down, Cellink AB is expected to follow. At this point, Cellink AB has a negative expected return of -0.44%. Please make sure to confirm Cellink AB's total risk alpha, as well as the relationship between the daily balance of power and price action indicator , to decide if Cellink AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cellink AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's forward-looking signals remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 808.7 M | |
| Total Cashflows From Investing Activities | -4.5 B | |
| Free Cash Flow | -676.2 M |
Cellink |
Cellink AB Relative Risk vs. Return Landscape
If you would invest 437.00 in Cellink AB on August 31, 2024 and sell it today you would lose (136.00) from holding Cellink AB or give up 31.12% of portfolio value over 90 days. Cellink AB is currently producing negative expected returns and takes up 5.0245% volatility of returns over 90 trading days. Put another way, 44% of traded pink sheets are less volatile than Cellink, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cellink AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellink AB's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Cellink AB, and traders can use it to determine the average amount a Cellink AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0874
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLLKF |
Estimated Market Risk
| 5.02 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.44 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cellink AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellink AB by adding Cellink AB to a well-diversified portfolio.
Cellink AB Fundamentals Growth
Cellink Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cellink AB, and Cellink AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cellink Pink Sheet performance.
| Return On Equity | 0.0068 | |||
| Return On Asset | -0.025 | |||
| Profit Margin | 0.02 % | |||
| Current Valuation | 973.88 M | |||
| Shares Outstanding | 69.07 M | |||
| Price To Book | 1.23 X | |||
| Price To Sales | 4.61 X | |||
| Revenue | 1.26 B | |||
| EBITDA | 37.7 M | |||
| Total Debt | 1.35 B | |||
| Debt To Equity | 0.26 % | |||
| Cash Flow From Operations | (409.2 M) | |||
| Earnings Per Share | 0.06 X | |||
| Total Asset | 9.75 B | |||
About Cellink AB Performance
By analyzing Cellink AB's fundamental ratios, stakeholders can gain valuable insights into Cellink AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cellink AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cellink AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.Things to note about Cellink AB performance evaluation
Checking the ongoing alerts about Cellink AB for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cellink AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cellink AB generated a negative expected return over the last 90 days | |
| Cellink AB has high historical volatility and very poor performance | |
| Cellink AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.26 B. Net Loss for the year was (227.6 M) with profit before overhead, payroll, taxes, and interest of 1.03 B. | |
| Cellink AB generates negative cash flow from operations | |
| About 39.0% of the company shares are held by company insiders |
- Analyzing Cellink AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cellink AB's stock is overvalued or undervalued compared to its peers.
- Examining Cellink AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cellink AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cellink AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cellink AB's pink sheet. These opinions can provide insight into Cellink AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cellink Pink Sheet analysis
When running Cellink AB's price analysis, check to measure Cellink AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellink AB is operating at the current time. Most of Cellink AB's value examination focuses on studying past and present price action to predict the probability of Cellink AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellink AB's price. Additionally, you may evaluate how the addition of Cellink AB to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |